fatnews.com Home page  >  Article | Previous article | Next article

SEARCH

QUICKLINKS AND VIEW OPITONS

  • Categories of Articles
  • Summary View
  • Headline View
  • Archive of Quotes
  • Contact Us
  • Follow @fatnews

    Belviq (lorcaserin) causes weight loss of 3 to 3.7% more than placebo


    Posted by .(JavaScript must be enabled to view this email address)
    Wednesday, June 27, 2012 10:50 am Email this article
    Studies of the new weight loss drug Belviq (lorcaserin) for up to one year showed that increased weight loss by (only) 3 to 3.7 percent more than placebo. The drug was approved by the U.S. Food and Drug Administration today, June 27, 2012.

    REFERENCE

    Fda. Fda approves belviq [lorcaserin hydrochloride] to treat some overweight or obese adults. FDA News Press Release. 2012 Jun 27,
    http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm309993.htm

     

    Articles on the same subject can be found here:


    COMMENTS

    Please feel free to share your comments about this article.


    Name:

    Email:

    Comments:

    Please enter the word you see in the image below:


    Remember my personal information

    Notify me of follow-up comments?



    © Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.